300199 翰宇藥業
按盤價 
21.060 +1.050 (+5.247%)
21.060 +1.050 (+5.247%) | 2025/09 - 九個月 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 11.623 | -25.968 | -50.642 | -25.955 | 1.912 |
| 總資產報酬率 ROA (%) | 2.310 | -5.526 | -14.920 | -9.858 | 0.777 |
| 投入資產回報率 ROIC (%) | 2.745 | -6.471 | -17.110 | -11.247 | 0.873 | 邊際利潤分析 |
| 銷售毛利率 (%) | 59.845 | 57.092 | 49.306 | 77.336 | 72.042 |
| 營業利潤率 (%) | 13.507 | -27.344 | -117.646 | -52.647 | 5.313 |
| 息稅前利潤/營業總收入 (%) | 25.201 | -8.212 | -89.442 | -37.669 | 17.970 |
| 淨利潤/營業總收入 (%) | 10.212 | -30.514 | -119.486 | -52.895 | 3.864 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 85.862 | 72.557 | 89.426 | 59.104 | -701.260 |
| 價值變動淨收益/利潤總額(%) | 3.284 | -0.952 | -6.790 | 24.078 | 1,105.394 |
| 營業外收支淨額/利潤總額(%) | -5.317 | 0.632 | 0.704 | 0.539 | -16.096 | 償債能力分析 |
| 流動比率 (X) | 0.373 | 0.325 | 0.480 | 0.708 | 1.553 |
| 速動比率 (X) | 0.183 | 0.158 | 0.373 | 0.542 | 1.342 |
| 資產負債率 (%) | 78.992 | 80.153 | 76.101 | 64.086 | 57.813 |
| 帶息債務/全部投入資本 (%) | 71.391 | 72.014 | 68.751 | 55.195 | 49.725 |
| 股東權益/帶息債務 (%) | 33.896 | 31.933 | 38.717 | 72.944 | 92.826 |
| 股東權益/負債合計 (%) | 25.919 | 23.998 | 30.425 | 54.904 | 70.167 |
| 利息保障倍數 (X) | 2.036 | -0.425 | -3.080 | -2.468 | 1.342 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 37.076 | 72.623 | 189.181 | 148.743 | 143.063 |
| 存貨周轉天數 (天) | 259.260 | 278.077 | 281.953 | 391.397 | 300.840 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 31/10/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
